MedPage Today on MSN
Expand labeling for testosterone replacement therapy, FDA panel says
Members of an FDA expert panel urged the agency to expand labeling for testosterone replacement therapy and remove its ...
The narrow FDA labeling makes it so that only a minority of men who could benefit from treatment are considered ‘on-label’ ...
The drugs have soared in popularity, with some men taking them for unapproved uses like anti-aging or increasing muscle mass.
At an FDA discussion of testosterone replacement therapy, a top official called for special health centers to address a ...
An FDA panel pushes reclassify testosterone therapy by recommending removal of controlled substance status and expanding treatment eligibility.
Testosterone replacement therapy (TRT) is linked to a significantly lower risk of major CV events in men with secondary hypogonadism.
Recently, much has been written about testosterone and male hormone replacement therapies. Symptoms of low testosterone may include fatigue, loss of muscle mass and increased abdominal fat. Other ...
News-Medical.Net on MSN
Indiana University physician joins FDA panel on male hormone therapy
Helen Bernie, DO, MPH, assistant professor of urology at Indiana University School of Medicine, will participate in an expert ...
Here’s what science actually shows about declining testosterone in young adults, and why treatment is rarely the first answer ...
Although he initially chalked up his symptoms to age, Wayne Masse decided to see his doctor about the fatigue, depression, hot flashes and sexual problems he had been dealing with. “Erections weren’t ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results